Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Hematopoietic stem cell transplantation in T-cell lymphomas: A promising strategy challenging poor prognosis

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAmaya Llorente‐ChávezRFRodrigo Figueroa-MéndezITIldefonso Téllez

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows hematopoietic stem cell transplantation improves outcomes in T-cell lymphomas, suggesting its potential in advanced disease.

Key Points

  • Hematopoietic stem cell transplantation improved overall and progression-free survival in T-cell lymphomas.
  • A total of 40 patients with various T-cell lymphoma subtypes were treated, documenting diverse responses.
  • Analysis included comparisons of outcomes between autologous and allogeneic transplantation methods.
  • The findings highlight the importance of HSCT in T-cell lymphomas, especially as a consolidation strategy.

Cite This Study

Llorente‐Chávez et al. (2025) studied this question.

synapsesocial.com/papers/69362f484fa91c937236d73fhttps://doi.org/10.1182/blood-2025-7151
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparable outcomes after autologous hematopoietic cell transplantation in T-cell lymphoma regardless of pre-transplant response: A key finding in resource-limited countries.2025
  2. 2The role of hematopoietic stem cell transplantation in peripheral T-cell lymphoma not otherwise specified2025
  3. 3Peripheral T-cell lymphomas: Real-world insights into clinical features and prognosis2025 · 1 citations
  4. 4Real world outcome of nodal T cell non-Hodgkin lymphoma from hematology cancer consortium registry in India2025
  5. 5Real-world treatment and outcomes of Mantle Cell Lymphoma in Latin America: A multinational cohort analysis2025